A Research Study of the Effect of Etavopivat on Other Drugs in Healthy Participants

Clinical trial NCT06813924 · COMPLETED

Trial details

NCT number: NCT06813924
Sponsor: Novo Nordisk A/S
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Volunteers Sickle Cell Disease, Thalassemia

Start date: 2025-02-06
Primary completion: 2025-05-27
Enrollment: 37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.